@FiercePharma: ICYMI yesterday: Pfizer wins recommendation for Prevenar expansion in Europe. Story | Follow @FiercePharma
@EricPFierce: UAE-based Gulf Pharmaceuticals intends to build a $50M insulin plant in Ethiopia. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal. Article | Follow @CarlyHFierce
> Novo Nordisk ($NVO) says it is continuing with a plant in Russia, despite economic issues in the country, as it prepares itself for the future. Story
> The U.K. cost watchdog NICE has issued final guidance recommending Bayer blood thinner Xarelto to treat blood clots in patients who have had a heart attack. Release
> India's Biocon reported a 13% decline in net profit for the last quarter and says it will sell a 10% to 15% stake in its Syngene research unit. Report
> EU evaluators have recommended expanding approval of Novo Nordisk blood cancer treatment Jakavi to include polycythemia vera, a chronic incurable blood cancer. Report
> Hospira ($HSP) is recalling one lot of saline solution after human hair was found in a single unit. Report
Medical Device News
@FierceMedDev: Roche's Ventana inches closer to FDA approval for lung cancer companion Dx. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Welch Allyn buys eye exam provider, signaling move into services. Article | Follow @VarunSaxena2
@EmilyWFierce: Au revoir, Weber; Bonjour, Bohuon? FiercePharma article | Follow @EmilyWFierce
> Profit down 12% at Intuitive Surgical, but procedure volume up due to strength abroad and in general surgery. More
> France's bioMérieux and Astute Medical join forces on acute kidney injury test. Article
Biotech News
@FierceBiotech: EuroBiotech: EU IPOs obliterate recent highs, U.K. VC funding tops $700M, Woodford backs microbiome play. Report | Follow @FierceBiotech
@JohnCFierce: Interviewed the CEO at the new CAR-T player. Their CSO also worked on Bellicum program. Story | Follow @JohnCFierce
@DamianFierce: $MDCO's Clive Meanwell has by far the best name among biopharma CEOs. At least until someone appoints Guy Smiley. | Follow @DamianFierce
> The Medicines Co.'s FDA-rejected cardio drug finds EU success. Report
> GlaxoSmithKline's Ebola vaccine rolls into Phase III as outbreak simmers. Article
And Finally... Half a dozen execs at Auxilium Pharmaceuticals will share $31 million after cashing in stock options and awards following the completion of the buyout by Endo International ($ENDP), including CEO Adrian Adams, who will get $15.5 million alone. Story